Escobar Gabriel J, Ragins Arona, Li Sherian Xu, Prager Laura, Masaquel Anthony S, Kipnis Patricia
Division of Research, Systems Research Initiative and Perinatal Research Unit, Kaiser Permanente Medical Care Program, Oakland, California 94612, USA.
Arch Pediatr Adolesc Med. 2010 Oct;164(10):915-22. doi: 10.1001/archpediatrics.2010.177.
To quantify the relationship between recurrent wheezing (RW) in the third year of life and respiratory syncytial virus (RSV) infection, prematurity, and neonatal oxygen exposure.
Retrospective cohort study linking inpatient, outpatient, and laboratory databases for cohort assembly and logistic regression analysis.
Integrated health care delivery system in Northern California.
A total of 71,102 children born from 1996 to 2002 at 32 weeks' gestational age or later who were health plan members for 9 or more months in their first and third years.
Laboratory-confirmed, medically attended RSV infection during first year and supplemental oxygen during birth hospitalization.
Recurrent wheezing, quantified through outpatient visits, inpatient hospital stays, and asthma prescriptions.
The rate of RW in the third year of life was 16.23% among premature infants with RSV and 6.22% among those without RSV. The risk of RW increased among infants who had an RSV outpatient encounter (adjusted odds ratio [AOR], 2.07; 95% CI, 1.61-2.67), uncomplicated RSV hospitalization (AOR, 4.66; 95% CI, 3.55-6.12), or prolonged RSV hospitalization (AOR, 3.42; 95% CI, 2.01-5.82) compared with infants without RSV encounters. Gestational age of 34 to 36 weeks was associated with increased risk of RW (AOR, 1.23; 95% CI 1.07-1.41) compared with 38 to 40 weeks, while a gestational age of 41 weeks or more was protective (AOR, 0.90; 95% CI, 0.81-0.99). Supplemental oxygen exposure was associated with increased risk at all levels.
Laboratory-confirmed, medically attended RSV infection, prematurity, and exposure to supplemental oxygen during the neonatal period have independent associations with the development of RW in the third year of life.
量化生命第三年复发性喘息(RW)与呼吸道合胞病毒(RSV)感染、早产和新生儿吸氧之间的关系。
一项回顾性队列研究,通过链接住院、门诊和实验室数据库进行队列组建及逻辑回归分析。
北加利福尼亚的综合医疗保健服务系统。
1996年至2002年出生、孕龄32周及以后、在其出生第一年和第三年作为健康计划成员达9个多月的71102名儿童。
出生第一年实验室确诊且接受医疗护理的RSV感染,以及出生住院期间的吸氧情况。
通过门诊就诊、住院天数和哮喘处方来量化复发性喘息。
患有RSV的早产儿在生命第三年的RW发生率为16.23%,未感染RSV的早产儿为6.22%。与未发生RSV感染的婴儿相比,发生RSV门诊就诊(校正比值比[AOR],2.07;95%置信区间[CI],1.61 - 2.67)、单纯性RSV住院(AOR,4.66;95% CI,3.55 - 6.12)或长时间RSV住院(AOR,3.42;95% CI,2.01 - 5.82)的婴儿发生RW的风险增加。与孕龄38至40周相比,孕龄34至36周与RW风险增加相关(AOR,1.23;95% CI为1.07 - 1.41),而孕龄41周及以上具有保护作用(AOR,0.90;95% CI,0.81 - 0.99)。在所有吸氧水平下,吸氧与风险增加相关。
实验室确诊且接受医疗护理的RSV感染、早产以及新生儿期吸氧与生命第三年RW的发生存在独立关联。